Skip to main content

Consultations

Consult with experienced clinical trialists and experts in recruitment

Investigators are invited to request a consultation from the Trial Innovation Network for multicenter clinical trials and studies. Consultations are designed to help investigators, for example, develop proposals into protocols, enhance study operations, or improve recruitment and retention. Topics covered during consultations may include the underlying scientific premise, the study outcomes, approaches to statistical analyses, and other discrete services.

To learn more about the consultation process, view the TIN's Proposal Process.

46
SIRB projects supported
by Utah TIC

70
Initial consults provided
by the Utah TIC

11
Consults receiving
comprehensive support

73
Institutions Utah TIC has
supported with SIRB

Testimonials from Investigators Following Consult Services

The TIC has provided timely feedback as I navigate protocol revisions required by ongoing discussions with the FDA, NIH, and the IRB. This has all been quite helpful.
Trial Investigator
Wow! This came together super fast and I am just amazed with the teams.
Trial Investigator
The group was very helpful and responsive with a lot of practical advice and flexible support options - all within a very tight timeline. It is well-organized and filled in some diffcult ‘gaps’ in putting this proposal together. I very much hope we are funded and that we have the opportunity to work together.
Trial Investigator

Use Cases for Consultations & TIC Support

Comprehensive Consult #1

Trial Characteristics -

  • 200 adult participants, 10 sites
  • Adults who need a major limb amputation
  • Compare amputation procedures and development of painful neuromas

 

TIC Support -

  • Research strategy and statistical design
  • Budget support
  • Grant mechanism identification
  • Community Engagement Studio
  • TIN Consult: June 2019 - September 2020

Comprehensive Consult #2

Trial Characteristics -

  • 100 participants, 11 sites (including 1 international site)
  • Age 0-18, critically ill and supported by ECMO
  • Demonstrate the efficacy of restrictive as compared to liberal platelet transfusion strategy

 

TIC Support -

  • Research strategy and statistical design
  • Budget refinement
  • SIRB support and EFIC support
  • Status: May 2020 - Ongoing